PSA Doubling Time Calculator
PDF) Disease-specific outcomes of Radical Prostatectomies in Northern Norway; A case for the impact of perineural infiltration and postoperative PSA-doubling time
PSA Doubling Time Calculator
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Month 134 – PSA Results | Dan's Journey through Prostate Cancer
Prostate Cancer Nomograms: PSA Doubling Time | Memorial Sloan Kettering Cancer Center
PSA Doubling Time Calculator
GitHub - conan-koh123/Calculating-PSA-Doubling-Time-for-many-patients: R code to calculate PSA doubling time (in months) for many patients
PSA Doubling Time Calculator
PSA doubling time predicts the outcome after active surveillance in screening‐detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section - Ali - 2007 - International
Introduction Evidence Based Radiation Oncology Fact Sheets Prostate Cancer 2022
Practical rules for calculating PSA doubling time
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis | Nature Medicine
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect
Rates of change in PSA (ng/ml/yr) and PSA doubling time (yr) for... | Download Table
The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer | Prostate Cancer and Prostatic Diseases
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Prostate Cancer Calculators
PSA doubling time predicts the outcome after active surveillance in screening‐detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section - Ali - 2007 - International
Low detectable PSA after prostatectomy – watch or treat? | THE "NEW" PROSTATE CANCER INFOLINK
Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer | Prostate Cancer and Prostatic Diseases
